bestshares.com Logo
Popular
  • NVDA
    NVDA Nvidia
  • GOOGL
    GOOGL Alphabet Inc.
  • AAPL
    AAPL Apple Inc.
  • MSFT
    MSFT Microsoft Corporation
  • AMZN
    AMZN Amazon.com, Inc.
  • SPY
    SPY SPDR S&P 500 ETF Trust
  • QQQ
    QQQ Invesco QQQ Trust
    • Ultragenyx Pharmaceutical Inc. logo

    Ultragenyx Pharmaceutical Inc.

    RARE | NASDAQ
    Chart Builder DCF Calculator
    $14.65
    +$0.14 (+0.96%)
    At close: Sep 21, 2026, 4:00 PM ET
    $14.78
    +$0.13 (+0.86%)
    Pre-market: Sep 22, 2026, 4:56 AM ET
    Overview Rating Statistics Financials Earnings Analysts Ownership Profile

    Market Data

    Market Cap
    $1.43B
    Enterprise Value
    $2.35B
    Beta
    0.32
    Average Volume
    2.6M
    Shares Outstanding (Diluted)
    101.9M
    Shares Change YoY
    3.49%
    Institutional Ownership
    97.57%
    Exchange
    NASDAQ
    ISIN
    US90400D1081

    Price Performance

    Price Change 1M
    -43.5%
    Price Change 3M
    -49.1%
    Price Change 6M
    -26.2%
    Price Change YTD
    -37.9%
    Price Change 1Y
    -50.3%
    Price Change 3Y
    -59.8%
    Price Change 5Y
    -84.6%
    1M CAGR (ann.)
    -43.8%
    1Y CAGR (ann.)
    -49.5%
    5Y CAGR (ann.)
    -32.3%
    All-Time CAGR
    -8.1%

    Valuation

    PE Ratio
    -2.51
    Forward PE
    21.76
    PEG Ratio
    0.40
    Forward PEG
    0.03
    PS Ratio
    2.01
    Forward PS
    1.40
    PB Ratio
    -4.96
    P/FCF Ratio
    -2.95
    P/Adj. FCF Ratio
    -2.30
    P/OCF Ratio
    -3.08
    EV/Sales
    3.28
    EV/EBIT
    -4.65
    EV/EBITDA
    -4.97
    EV/FCF
    -4.81
    Earnings Yield
    -39.9%
    FCF Yield
    -33.9%
    Adj. FCF Yield
    -43.5%

    Financial Health

    Net Debt
    $910M
    Total Debt
    $1.2B
    Cash & Short-Term Investments
    $292M
    Total Assets
    $1.26B
    Current Ratio
    1.73
    Quick Ratio
    1.56
    Debt / Equity Ratio
    -4.13
    Debt / EBITDA
    -2.54
    Debt / FCF
    -2.46
    OCF / Debt
    -0.40
    Interest Coverage
    -6.95
    Altman Z-Score
    -5.29
    Piotroski F-Score
    2

    Margins & Profitability

    Gross Profit Margin
    83.1%
    Operating Profit Margin
    -73.8%
    EBITDA Margin
    -66.0%
    Net Profit Margin
    -81.8%
    FCF Margin
    -68.3%
    Adj. FCF Margin
    -87.6%
    SBC / Revenue
    19.3%
    SBC Impact (per share)
    -28.2%

    Returns

    Return on Assets
    -46.4%
    Return on Equity
    392.4%
    Return on Invested Capital
    -53.5%
    Return on Capital Employed
    -57.9%
    Return on Tangible Assets
    -56.0%

    Historical Growth (CAGR)

    Revenue CAGR 3Y
    21.2%
    Revenue CAGR 5Y
    14.8%
    Revenue CAGR 10Y
    190.1%
    EPS CAGR 3Y
    11.7%
    EPS CAGR 5Y
    10.6%
    EPS CAGR 10Y
    -1.8%
    FCF CAGR 3Y
    0.3%
    FCF CAGR 5Y
    0.5%
    FCF CAGR 10Y
    -8.6%

    Analyst Forecasts

    Analyst Rating
    Buy
    Analyst Count
    33
    EPS Growth Next 3Y
    40.2%
    Revenue Growth Next 3Y
    21.7%
    Earnings Date
    Nov 2, 2026
    EPS Estimate (next Q)
    -$0.65
    EPS Growth Est (next Q)
    -64.1%
    Revenue Est (next Q)
    $183.18M
    Revenue Growth Est (next Q)
    14.5%

    Fair Value Estimates

    Graham Number
    N/A
    Graham Upside
    N/A
    Lynch Fair Value
    N/A
    Lynch Upside
    N/A
    Price Target
    $25.83
    Price Target Upside
    76.3%

    Cash Flow

    Operating Cash Flow
    $-485.25M
    Free Cash Flow
    $-489.47M
    Adj. Free Cash Flow
    $-627.77M
    FCF Per Share
    -$4.80
    OCF Per Share
    -$4.76
    OCF/S Ratio
    -67.7%

    Income Statement

    Revenue
    $716.93M
    Gross Profit
    $595.94M
    Operating Income
    $-528.89M
    EBITDA
    $-473M
    Net Income
    $-586.41M
    EPS (Diluted)
    -$5.84
    Revenue / Employee
    $522.93K
    Profit / Employee
    $-427.73K
    Employees
    1,371

    © 2026 bestshares.com. All rights reserved.